A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 115
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SFRP4
Long Form : secreted frizzled-related protein 4
No. Year Title Co-occurring Abbreviation
2022 Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study. EC, NF-kappaB, OC, Romo1, TFF3
2022 Downregulation of secreted frizzled-related protein 4 inhibits hypoxia/reoxygenation injury in diabetic cardiomyocytes by protein tyrosine phosphatase nonreceptor type 12. I/R, PTPN12
2022 Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging. SASP
2022 Identification of Ascorbic Acid and Gallic Acid as Novel Inhibitors of Secreted Frizzled-Related Protein for the Treatment of Obesity-Induced Type 2 Diabetes. AA, GA, T2D
2022 Identification of senescence-related molecular subtypes and key genes for prostate cancer. ALDH2, APOE, BCR, CAFs, CD38, COMP, CXCL14, FAM107A, HAVCR2, LUZP2, NRP-1, PARM1, PCa, PTN, RP, RT, TME, VGLL3
2022 Impact of Human Papillomavirus on Wnt/Beta-Catenin Signaling in Morphological Inconspicuous Cervicovaginal Cells. HPV
2022 Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stress. CAD, HFD
2022 SFRP4 and CDX1 Are Predictive Genes for Extragastric Recurrence of Early Gastric Cancer after Curative Resection. CDX1, EGC, FFPE, OR, SPC
2022 SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. ---
10  2022 The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization. ANKH, CKD, CKD-MBD, DKK1
11  2021 Demethylation of the SFRP4 Promoter Drives Gastric Cancer Progression via the Wnt Pathway. GEO, SFRP, TNM
12  2021 Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren's Contracture. DC, RSPO2, WNT7B
13  2021 MeCP2 attenuates cardiomyocyte hypoxia/reperfusion-induced injury via regulation of the SFRP4/Wnt/beta-catenin axis. MDA, MeCP2, ROS, SOD
14  2021 Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG. CRD, MMP-2, NLD
15  2021 Oocyte-secreted factors strongly stimulate sFRP4 expression in human cumulus cells. BMP15, CCs, GDF9
16  2021 Secreted frizzled-related protein 4 promotes brown adipocyte differentiation. IL-1beta
17  2021 Wingless-type mouse mammary tumor virus integration site regulation of bovine theca cells. BMP-7, DKK1, FGF9, IGF1, Ihh, LH, RSPO1, TCs, WNT3A
18  2020 EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines. CBX7, CRCs, EZH2, JARID2, PcG, PRCs
19  2020 First trimester secreted Frizzled-Related Protein 4 and other adipokine serum concentrations in women developing gestational diabetes mellitus. AUC
20  2020 Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia. CTR, ePPi, FGF23, FGF7, HPP, Pi, TNSALP, XLH
21  2020 Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions. ---
22  2020 SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence. ---
23  2020 The First Report of Biallelic Missense Mutations in the SFRP4 Gene Causing Pyle Disease in Two Siblings. ---
24  2019 Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight. scWAT
25  2019 Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome. BMI, PCOS
26  2019 Histone demethylase KDM4A regulates adipogenic and osteogenic differentiation via epigenetic regulation of C/EBPalpha and canonical Wnt signaling. ---
27  2019 Interference of miR-943-3p with secreted frizzled-related proteins4 (SFRP4) in an asthma mouse model. BALF, DEGs, EOS, LYM, mac, NEU, OVA
28  2019 Secreted frizzled-related protein 4 and its implication in obesity and type-2 diabetes. IL1-beta, T2D, Wnt
29  2019 Secreted Frizzled-related protein 4 inhibits the regeneration of hair follicles. ---
30  2019 SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients. EMT
31  2019 SFRP4 is a prognostic marker and correlated with Treg cell infiltration in pancreatic ductal adenocarcinoma. GEO, KPC, PDAC
32  2018 Differential Patterns of Secreted Frizzled-Related Protein 4 (SFRP4) in Adipocyte Differentiation: Adipose Depot Specificity. eWAT, iWAT
33  2018 Finding Novel Anti-carcinomas Compounds by Targeting SFRP4 Through Molecular Modeling, Docking and Dynamic Simulation Studies. MD
34  2018 Idiopathic infertility in women is associated with distinct changes in proliferative phase uterine fluid proteins. CD44, ECM1
35  2018 Increased secreted frizzled-related protein 4 and ficolin-3 levels in gestational diabetes mellitus women. CI, GDM, NGT, OR, T2DM
36  2018 Morphological and molecular characterization of the senile osteoporosis in senescence-accelerated mouse prone 6 (SAMP6). SAMP6
37  2018 Morphology-oriented epigenetic research. HELMET, RANKL, RCA
38  2018 Prorenin and secreted frizzled-related protein 4 levels in women with gestational diabetes mellitus. GDM, OGTT
39  2018 Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4). CSCs, OXPHOS
40  2018 Secreted frizzled related protein 4 (sFRP4) update: A brief review. ---
41  2018 Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma. ChIP, ETS2, GSCs
42  2018 The Influence of Breast Tumour-Derived Factors and Wnt Antagonism on the Transformation of Adipose-Derived Mesenchymal Stem Cells into Tumour-Associated Fibroblasts. ADSCs, TAFs, TCM
43  2018 [Expression of secreted frizzled-related protein 4 in DNA mismatch repair-deficient and mismatch repair-proficient colorectal cancers]. dMMR, IHC
44  2017 A novel sequence variant in SFRP4 causing Pyle disease. PYL
45  2017 A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas. ChIP-qPCR, PR
46  2017 Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt beta-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4. CSCs, DG
47  2017 Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects. CRD, MM, NLD
48  2017 Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators. Dkk, MSCs, WJ-MSCs
49  2017 hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells. cAMP, ESCs, HOXA10, PKA, PR
50  2017 Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease. CAD, EAT, ELISA, HOMA-IR, SAT
51  2017 Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer. PDAC
52  2017 Paracrine Secreted Frizzled-Related Protein 4 Inhibits Melanocytes Differentiation in Hair Follicle. ---
53  2017 Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines. CSCs
54  2017 SFRP4 gene expression is increased in aggressive prostate cancer. ---
55  2017 sFRP4 signalling of apoptosis and angiostasis uses nitric oxide-cGMP-permeability axis of endothelium. NO
56  2017 The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines. ---
57  2016 Cross-talk of SFRP4, integrin alpha1beta1, and Notch1 inhibits cardiac differentiation of P19CL6 cells. FAK, NICD1, p-FAK Y397
58  2016 Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus. CO, CO-T1D, LADA, T1D, T2D
59  2016 Secreted Frizzled-Related Protein 4 (SFRP4): A Novel Biomarker of beta-Cell Dysfunction and Insulin Resistance in Individuals With Prediabetes and Type 2 Diabetes. ---
60  2016 Tet proteins influence the balance between neuroectodermal and mesodermal fate choice by inhibiting Wnt signaling. 5hmC, 5mC, mESCs, NMPs
61  2016 Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells. GSK-3beta, MM
62  2015 Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice. WNT
63  2015 MicroRNA-124 Regulates Cell Specification in the Cochlea through Modulation of Sfrp4/5. ---
64  2015 miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis. CK19, EMT, miRNAs, OSF, TM4SF1
65  2015 Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes. miR-103, pre-DM
66  2015 Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties. CSCs, EMT, TMZ
67  2015 Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease. ADPKD, TKV
68  2015 Wnt antagonist secreted frizzled-related protein 4 upregulates adipogenic differentiation in human adipose tissue-derived mesenchymal stem cells. ADSCs, BIO, LiCl, PPARgamma
69  2014 Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease. SFRP
70  2014 Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition. CSCs, EMT, HNSCC
71  2014 Computer aided screening of secreted frizzled-related protein 4 (SFRP4): a potential control for diabetes mellitus. ---
72  2014 Elevated secreted frizzled-related protein 4 in obesity: a potential role in adipose tissue dysfunction. AbdAT, GlutAT
73  2014 Intrinsic multipotential mesenchymal stromal cell activity in gelatinous Heberden's nodes in osteoarthritis at clinical presentation. BM, BMP4, BMPR1A, HNs, MSCs, OA, PRELP, SF, TNFAIP6
74  2014 MicroRNA-152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model. 5-aza-dC, DNMT, FLS, MeCP2, MiRNAs, NiS, RA
75  2014 Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer. RQ
76  2014 PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma. BCC, BSCC, Hh
77  2014 Secreted frizzled-related protein 4 (SFRP4) and fractalkine (CX3CL1) - Potential new biomarkers for beta-cell dysfunction and diabetes. T2DM
78  2014 Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. ---
79  2014 Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells. CSCs, GSCs
80  2013 Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia. IHC, PE
81  2013 The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. EMP, MET, rSFRP4
82  2013 [Chuju total flavonoids control the SFRP4 expression in Wnt pathway in rheumatoid arthritis model rats]. CJTF, RA
83  2012 Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. ---
84  2012 MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats. 5-aza-dC, ACPA, FLS, RA
85  2012 The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro. CRD, NLD
86  2011 Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. FABP4, GPR109A, IL-6, PPARgamma, RGS2, TGF-beta1, TNF-alpha
87  2011 Expression and regulation of sFRP family members in human granulosa cells. GCs
88  2011 Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasis. FGF23
89  2011 Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer. EPE, MIC-1, PC, RP, SVI
90  2011 Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. ATRA, PSCs, RA
91  2011 [Animal models for bone and joint disease. Genetic analysis of low BMD in SAMP6 mice]. BMD
92  2010 Secreted frizzled related protein 4 reduces fibrosis scar size and ameliorates cardiac function after ischemic injury. GSK
93  2010 Secreted frizzled-related protein 4: an angiogenesis inhibitor. ---
94  2010 Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis. BMD, Npt, SFRP, Tb.Th, WT
95  2009 Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study. DKK1, PS
96  2009 Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours. ---
97  2009 Expression of secreted frizzled-related protein 4 in the primate placenta. ---
98  2009 Wnt antagonist gene polymorphisms and renal cancer. C/T, DKK2, G/A, G/C, RCC, rs17037102, SNPs, WNT
99  2008 Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma. DVL2, FZD2, FZD3, LRP5, RT, WNT5A
100  2008 Increased expression of secreted frizzled-related protein 4 in polycystic kidneys. ADPKD